Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

Anthropic PBC​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
A

Anthropic PBC

Ask AI
ProfileEntity StructureEDINET FilingsAll Documents

Overview

ProfileEntity Structure

Documents

SEC Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

Anthropic PBC​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
A

Anthropic PBC

Ask AI
ProfileEntity StructureEDINET FilingsAll Documents

Overview

ProfileEntity Structure

Documents

SEC Filings
EDINET Filings
All Documents
EDINET Filings
All Documents

Anthropic PBC — Company Profile

Latest Documents

SEC Filings(24)

Expand
  • Form 3Razavi Yasmin09:05PM
  • Form 3Rao Krishna09:04PM
  • Form 3Ng Effendi09:03PM
  • Form 3Narasimhan Vasant09:02PM
  • Form 3LIDDELL CHRISTOPHER P09:01PM
  • Form 3HASTINGS REED09:00PM
  • Form 3Amodei Daniela08:59PM
  • Form 3Amodei Dario08:58PM
  • S-1MEFRegistration statement (additional securities)06:42PM
  • CERTCERT09:12AM
  • FWPFree writing prospectus12 Nov
  • FWPFree writing prospectus12 Nov
  • FWPFree writing prospectus10 Nov
  • FWPFree writing prospectus10 Nov
  • FWPFree writing prospectus10 Nov
  • S-1/ARegistration statement (general form, amendment)10 Nov
  • S-1/ARegistration statement (general form, amendment)2 Nov
  • S-1Registration statement (general form)26 Oct
  • DRS/ADraft registration statement (amendment)9 Oct
  • DRS/ADraft registration statement (amendment)30 Sep

EDINET Filings(6)

Expand
  • PRSAmended Securities Registration Statement07:00PM
  • PRSAmended Securities Registration Statement17 Nov
  • PRSAmended Securities Registration Statement17 Nov
  • IRExtraordinary Report11 Nov
  • PRSAmended Securities Registration Statement4 Nov
  • PRSSecurities registration statement2 Nov

Mentions in Filings

  • A
    … fianceETFs.com. **Important Information About the Fund** The Defiance 2X ANT Long Daily ETF (the “Fund”) seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of <strong>Anthropic, PBC</strong> (Nasdaq: ANT) (the “Underlying Security” or “ANT”). Because the Fund seeks daily leveraged investment results, it is very different from most other exchange-traded funds. It is also riskier than alternatives that do n …
    Tidal Trust IIAnthropic PBC·497K - Form 497K - SUMMARY PROSPECTUS·Q4 26·17 Nov
  • A
    The Fund seeks daily inverse investment results, before fees and expenses, of -2 times (-200%) the daily percentage change in the share price of <strong>Anthropic, PBC</strong> (Nasdaq: ANT). The Fund does not seek to achieve its stated investment objective for a period other than a single trading day. **Fees and Expenses of the Fund** This table describes the fees and expenses that you may pay if you buy, hold, and sell shares of the Fund (“Shares”). **You may …
    Tidal Trust IIAnthropic PBC·497K - Form 497K - SUMMARY PROSPECTUS·Q4 26·17 Nov
  • A
    … [email protected]. **Investment Objective** The Fund’s primary investment objective is to seek current income. The Fund’s secondary investment objective is to seek exposure to the share price of common stock of <strong>Anthropic, PBC</strong> (NASDAQ: ANT) (the “Underlying Security” or “ANT”), subject in certain circumstances to a limit on the Fund’s participation in gains. **Fees and Expenses of the Fund** This table describes the fees and expenses that …
    Tidal Trust IIAnthropic PBC·497K - Form 497K - SUMMARY PROSPECTUS·Q4 26·17 Nov
  • A
    … made by the Adviser’s investment committee and are not made by or delegated to AI tools. As of the date hereof, these tools include enterprise generative artificial intelligence services, based on large language models, that are provided by third parties (currently Google LLC (Gemini), OpenAI (ChatGPT) and <strong>Anthropic, PBC</strong> (Claude)), and are made available to the Adviser and its affiliates under enterprise arrangements maintained by Rise Companies.
    Fundrise Innovation Fund II, LLCAnthropic PBC·424B3 - Prospectus filing (Rule 424(b)(3))·Q3 27·13 Nov
  • A
    … stitute notice): Name: Willkie Farr & Gallagher LLP Address: 787 Seventh Avenue, New York, NY 10019-6099 Attn: Russell Leaf; Sean M. Ewen Email: [email protected]; [email protected] If to the Investor, to: Name: <strong>Anthropic, PBC</strong> Address: 548 Market Street, PMB 90375 San Francisco, CA 94104 Attn: Email: Email: With a copy to (which copy alone shall not constitute notice): Name: Davis Polk & Wardwell LLP Address: 450 Lexington Avenu …
    RUM Group Inc.Anthropic PBC·EX-4.1 - 10-Q - WARRANT AGREEMENT, DATED AS OF SEPTEMBER 30, 2026 Q3·Q3 26·12 Nov
  • A
    … ology organizations. These include existing collaborations with Amgen, Inc. (“Amgen”), Novartis Pharma AG (“Novartis”), and Roswell Park Comprehensive Cancer Center (“Roswell Park”), as well as new collaborations with <strong>Anthropic, PBC</strong> to evaluate AI-enabled workflows in selected research programs using access to its life sciences researchers and frontier AI models; and new collaboration with Zealand Pharma A/S (“Zealand”) to design and develop mult …
    Generate Biomedicines, Inc.Anthropic PBC·10-Q - Quarterly report Q3·Q3 26·12 Nov

Anthropic PBC — Company Profile

Latest Documents

SEC Filings(24)

Expand
  • Form 3Razavi Yasmin09:05PM
  • Form 3Rao Krishna09:04PM
  • Form 3Ng Effendi09:03PM
  • Form 3Narasimhan Vasant09:02PM
  • Form 3LIDDELL CHRISTOPHER P09:01PM
  • Form 3HASTINGS REED09:00PM
  • Form 3Amodei Daniela08:59PM
  • Form 3Amodei Dario08:58PM
  • S-1MEFRegistration statement (additional securities)06:42PM
  • CERTCERT09:12AM
  • FWPFree writing prospectus12 Nov
  • FWPFree writing prospectus12 Nov
  • FWPFree writing prospectus10 Nov
  • FWPFree writing prospectus10 Nov
  • FWPFree writing prospectus10 Nov
  • S-1/ARegistration statement (general form, amendment)10 Nov
  • S-1/ARegistration statement (general form, amendment)2 Nov
  • S-1Registration statement (general form)26 Oct
  • DRS/ADraft registration statement (amendment)9 Oct
  • DRS/ADraft registration statement (amendment)30 Sep

EDINET Filings(6)

Expand
  • PRSAmended Securities Registration Statement07:00PM
  • PRSAmended Securities Registration Statement17 Nov
  • PRSAmended Securities Registration Statement17 Nov
  • IRExtraordinary Report11 Nov
  • PRSAmended Securities Registration Statement4 Nov
  • PRSSecurities registration statement2 Nov

Mentions in Filings

  • A
    … fianceETFs.com. **Important Information About the Fund** The Defiance 2X ANT Long Daily ETF (the “Fund”) seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of <strong>Anthropic, PBC</strong> (Nasdaq: ANT) (the “Underlying Security” or “ANT”). Because the Fund seeks daily leveraged investment results, it is very different from most other exchange-traded funds. It is also riskier than alternatives that do n …
    Tidal Trust IIAnthropic PBC·497K - Form 497K - SUMMARY PROSPECTUS·Q4 26·17 Nov
  • A
    The Fund seeks daily inverse investment results, before fees and expenses, of -2 times (-200%) the daily percentage change in the share price of <strong>Anthropic, PBC</strong> (Nasdaq: ANT). The Fund does not seek to achieve its stated investment objective for a period other than a single trading day. **Fees and Expenses of the Fund** This table describes the fees and expenses that you may pay if you buy, hold, and sell shares of the Fund (“Shares”). **You may …
    Tidal Trust IIAnthropic PBC·497K - Form 497K - SUMMARY PROSPECTUS·Q4 26·17 Nov
  • A
    … [email protected]. **Investment Objective** The Fund’s primary investment objective is to seek current income. The Fund’s secondary investment objective is to seek exposure to the share price of common stock of <strong>Anthropic, PBC</strong> (NASDAQ: ANT) (the “Underlying Security” or “ANT”), subject in certain circumstances to a limit on the Fund’s participation in gains. **Fees and Expenses of the Fund** This table describes the fees and expenses that …
    Tidal Trust IIAnthropic PBC·497K - Form 497K - SUMMARY PROSPECTUS·Q4 26·17 Nov
  • A
    … made by the Adviser’s investment committee and are not made by or delegated to AI tools. As of the date hereof, these tools include enterprise generative artificial intelligence services, based on large language models, that are provided by third parties (currently Google LLC (Gemini), OpenAI (ChatGPT) and <strong>Anthropic, PBC</strong> (Claude)), and are made available to the Adviser and its affiliates under enterprise arrangements maintained by Rise Companies.
    Fundrise Innovation Fund II, LLCAnthropic PBC·424B3 - Prospectus filing (Rule 424(b)(3))·Q3 27·13 Nov
  • A
    … stitute notice): Name: Willkie Farr & Gallagher LLP Address: 787 Seventh Avenue, New York, NY 10019-6099 Attn: Russell Leaf; Sean M. Ewen Email: [email protected]; [email protected] If to the Investor, to: Name: <strong>Anthropic, PBC</strong> Address: 548 Market Street, PMB 90375 San Francisco, CA 94104 Attn: Email: Email: With a copy to (which copy alone shall not constitute notice): Name: Davis Polk & Wardwell LLP Address: 450 Lexington Avenu …
    RUM Group Inc.Anthropic PBC·EX-4.1 - 10-Q - WARRANT AGREEMENT, DATED AS OF SEPTEMBER 30, 2026 Q3·Q3 26·12 Nov
  • A
    … ology organizations. These include existing collaborations with Amgen, Inc. (“Amgen”), Novartis Pharma AG (“Novartis”), and Roswell Park Comprehensive Cancer Center (“Roswell Park”), as well as new collaborations with <strong>Anthropic, PBC</strong> to evaluate AI-enabled workflows in selected research programs using access to its life sciences researchers and frontier AI models; and new collaboration with Zealand Pharma A/S (“Zealand”) to design and develop mult …
    Generate Biomedicines, Inc.Anthropic PBC·10-Q - Quarterly report Q3·Q3 26·12 Nov